Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Gains from Investment Securities (2020 - 2025)

Cytek Biosciences' Gains from Investment Securities history spans 6 years, with the latest figure at -$60000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 101.55% year-over-year to -$60000.0; the TTM value through Dec 2025 reached -$415000.0, down 110.84%, while the annual FY2025 figure was -$415000.0, 110.84% down from the prior year.
  • Gains from Investment Securities reached -$60000.0 in Q4 2025 per CTKB's latest filing, down from $2.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $10.4 million in Q4 2022 to a low of -$2.2 million in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $2.0 million, with a median of $294726.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: crashed 271.1% in 2021, then soared 55528.57% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$2.2 million in 2021, then skyrocketed by 564.25% to $10.4 million in 2022, then crashed by 100.07% to -$7000.0 in 2023, then skyrocketed by 55528.57% to $3.9 million in 2024, then crashed by 101.55% to -$60000.0 in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Gains from Investment Securities are -$60000.0 (Q4 2025), $2.8 million (Q3 2025), and -$1.6 million (Q2 2025).